Unlocking the potential of evidence-based medicine in a cost-contained market.
This new report covers the expanding role of pharmacoeconomics in pharmaceutical pricing and reimbursement decisions in key markets and its role in the product life cycle. It is designed to provide indispensable reference material in a format that allows easy comparison between countries.
Contents
-
What is pharmacoeconomics?
-
Pharmacoeconomic techniques
-
Pharmacoeconomic contexts
-
History of pharmacoeconomic evaluation
-
Pharmacoeconomic guidelines
-
The management of pharmacoeconomics
-
Pharmacoeconomic drivers
-
National pharmacoeconomic development: Comparative review of the development, use and regulators of pharmacoeconomics in selected markets:
Australia, Belgium, Canada, Denmark, Finland, France, Germany, Italy, Japan, Norway, Netherlands, Spain, Sweden, Switzerland, UK, USA.
